Abstract
A series of new cinnamide dimers was synthesized (5a-6a) and evaluated for their antimicrobial and antifungal activity. All the compounds investigated have shown significant antimicrobial activity against gram-positive and gram-negative bacterial strains, as well as few fungal strains. The compounds having withdrawing group exhibited significant biological activity than their precursors. Moreover all the compounds containing electron withdrawing substituent showed good antimicrobial activity in comparison with the standards.
Keywords: Antibacterial, Antifungal, Cinnamide dimers, Piperazine, antimicrobial activity, antifungal activity, methicillin resistant Staphylococcus aureus (MRSA), methicillin resistant epidermidis (MRSE), vancomycin, VRE, enterococci, Crixivan, N-Boc piperazine, Aspergillus
Letters in Drug Design & Discovery
Title: Synthesis of Cinnamide Dimers as Potential Antibacterial and Antifungal Agents
Volume: 8 Issue: 10
Author(s): Ahmed Kamal, G. Ramakrishna, P. Raju, A. V. Subba Rao, Joveeta Joseph, B. Siddhardha and U. S.N. Murty
Affiliation:
Keywords: Antibacterial, Antifungal, Cinnamide dimers, Piperazine, antimicrobial activity, antifungal activity, methicillin resistant Staphylococcus aureus (MRSA), methicillin resistant epidermidis (MRSE), vancomycin, VRE, enterococci, Crixivan, N-Boc piperazine, Aspergillus
Abstract: A series of new cinnamide dimers was synthesized (5a-6a) and evaluated for their antimicrobial and antifungal activity. All the compounds investigated have shown significant antimicrobial activity against gram-positive and gram-negative bacterial strains, as well as few fungal strains. The compounds having withdrawing group exhibited significant biological activity than their precursors. Moreover all the compounds containing electron withdrawing substituent showed good antimicrobial activity in comparison with the standards.
Export Options
About this article
Cite this article as:
Kamal Ahmed, Ramakrishna G., Raju P., V. Subba Rao A., Joseph Joveeta, Siddhardha B. and S.N. Murty U., Synthesis of Cinnamide Dimers as Potential Antibacterial and Antifungal Agents, Letters in Drug Design & Discovery 2011; 8 (10) . https://dx.doi.org/10.2174/157018011797655205
DOI https://dx.doi.org/10.2174/157018011797655205 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biosafety of Gene Therapy Vectors Derived From Herpes Simplex Virus Type 1
Current Gene Therapy Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-Infectives
Current Pharmaceutical Design Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics
Current Pharmaceutical Design Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Potential of Taming MicroRNA on Driver Seat to Control Mitochondrial Horses in Breast Carcinoma
MicroRNA Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets Focal Adhesion Kinase as a Cancer Therapy Target
Anti-Cancer Agents in Medicinal Chemistry Bioactive Components and Pharmacological Action of Wikstroemia indica (L.) C. A. Mey and Its Clinical Application
Current Pharmaceutical Biotechnology Chlorophylls and their Derivatives Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research Editorial (Thematic Issue: Research and Regulation: Challenges of Nanoproducts)
Recent Patents on Nanomedicine Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
Current Pharmaceutical Design Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design Targeted Therapies in Bone Sarcomas
Current Cancer Drug Targets Beneficial and Adverse Effects of Molecularly Targeted Therapies for Acute Promyelocytic Leukemia in Central Nervous System
CNS & Neurological Disorders - Drug Targets Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules
Current Molecular Pharmacology HIV-1 Vpr: A Closer Look at the Multifunctional Protein from the Structural Perspective
Current HIV Research Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells
MicroRNA Phosphoinositide 3-Kinases as Targets for Therapeutic Intervention
Current Pharmaceutical Design